Securities code: Cansino Biologics Inc(688185) securities abbreviation: Cansino Biologics Inc(688185) Announcement No.: 2022024 Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company
Announcement on realizing profit for the first time and canceling the special mark u for stock abbreviation
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Important content tips:
After canceling the special mark of stock abbreviation, Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company’s A-share stock abbreviation is changed from ” Cansino Biologics Inc(688185) -u” to ” Cansino Biologics Inc(688185) “, and the stock code of A-share Cansino Biologics Inc(688185) remains unchanged. Canceling the special mark will not have an impact on the company’s stock trading and other aspects.
The starting date of canceling the special identification U of stock abbreviation: March 29, 2022.
1、 Description of cancellation of special identification u for stock abbreviation
Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company (hereinafter referred to as ” Cansino Biologics Inc(688185) ” or “the company”) was listed on the science and Innovation Board of Shanghai Stock Exchange on August 13, 2020. In accordance with the Listing Rules of science and Innovation Board of Shanghai Stock Exchange, special provisions on science and Innovation Board of Shanghai Stock Exchange and notice on matters related to the trading of science and Innovation Board shares and depositary receipts and other relevant provisions, The company’s net profit attributable to the shareholders of the parent company in 2019 was -15678147969 yuan, and the net profit attributable to the shareholders of the parent company after deducting non recurring profits and losses was -17444509410 yuan. It was a non-profit enterprise at the time of listing. Therefore, since the date of listing of the company, the abbreviation of A-share stock is specially marked as ” Cansino Biologics Inc(688185) -u”.
The 2021 financial report of the company has been audited by Deloitte Touche Tohmatsu (special general partnership) and issued a standard unqualified audit report. According to the audit, the net profit attributable to the shareholders of the parent company in 2021 was 191439 Canny Elevator Co.Ltd(002367) yuan, and the net profit attributable to the shareholders of the parent company after deducting non recurring profits and losses was 179703773746 yuan; The annual report of the company for 2021 has been examined and approved by the board of directors. For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on March 28, 2022 Disclosed annual report of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company in 2021 and its summary.
According to the relevant provisions of the Listing Rules of Shanghai stock exchange for shares on the Kechuang board and the notice on matters related to the trading of shares on the Kechuang board and depositary receipts, the company’s net profit attributable to the shareholders of the parent company in 2021 and the net profit attributable to the shareholders of the parent company after deducting non recurring profits and losses are positive, which is in line with the situation of “the unprofitable company realized profit for the first time at the time of listing”, The abbreviation of the company’s A-share stock will cancel the special logo on March 29, 2022, change from ” Cansino Biologics Inc(688185) -u” to ” Cansino Biologics Inc(688185) “, and the A-share stock code Cansino Biologics Inc(688185) will remain unchanged.
2、 Description of other matters
According to the Listing Rules of Shanghai Stock Exchange’s Sci tech innovation board, the special provisions of Shanghai Stock Exchange on the trading of sci tech Innovation Board shares and the notice on matters related to the trading of sci tech Innovation Board shares and depositary receipts, the abbreviation of sci tech Innovation Board shares is specially marked to remind the company whether the company has unprofitable at the time of listing or has arrangements for differences in voting rights, The cancellation of the special mark u for the abbreviation of the company’s A-Shares will not have an impact on the company’s stock trading and other aspects.
It is hereby announced.
Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) board of directors March 28, 2022
